{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:08:13Z","timestamp":1791032893121,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T00:00:00Z","timestamp":1270166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00262-010-0851-z","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T12:06:16Z","timestamp":1270123576000},"page":"1443-1448","source":"Crossref","is-referenced-by-count":16,"title":["New strategies for the manipulation of adaptive immune responses"],"prefix":"10.1007","volume":"59","author":[{"given":"Tobias","family":"Bopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Radsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,2]]},"reference":[{"key":"851_CR1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86:2041\u20132050","journal-title":"Blood"},{"key":"851_CR2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151\u20131164","journal-title":"J Immunol"},{"key":"851_CR3","first-page":"3128","volume":"59","author":"S Onizuka","year":"1999","unstructured":"Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res 59:3128\u20133133","journal-title":"Cancer Res"},{"key":"851_CR4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.194.6.823","volume":"194","author":"RP Sutmuller","year":"2001","unstructured":"Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194:823\u2013832","journal-title":"J Exp Med"},{"key":"851_CR5","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1084\/jem.20042167","volume":"201","author":"AM Ercolini","year":"2005","unstructured":"Ercolini AM, Ladle BH, Manning EA, Pfannenstiel LW, Armstrong TD, Machiels JP, Bieler JG, Emens LA, Reilly RT, Jaffee EM (2005) Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med 201:1591\u20131602","journal-title":"J Exp Med"},{"key":"851_CR6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942\u2013949","journal-title":"Nat Med"},{"key":"851_CR7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.20041684","volume":"201","author":"P Yu","year":"2005","unstructured":"Yu P, Lee Y, Liu W, Krausz T, Chong A, Schreiber H, Fu YX (2005) Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 201:779\u2013791","journal-title":"J Exp Med"},{"key":"851_CR8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ni1059","volume":"5","author":"Y Yang","year":"2004","unstructured":"Yang Y, Huang CT, Huang X, Pardoll DM (2004) Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 5:508\u2013515","journal-title":"Nat Immunol"},{"key":"851_CR9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2005-10-4015","volume":"108","author":"T Warger","year":"2006","unstructured":"Warger T, Osterloh P, Rechtsteiner G, Fassbender M, Heib V, Schmid B, Schmitt E, Schild H, Radsak MP (2006) Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 108:544\u2013550","journal-title":"Blood"},{"key":"851_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","volume":"204","author":"K Lahl","year":"2007","unstructured":"Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204:57\u201363","journal-title":"J Exp Med"},{"key":"851_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.188.2.287","volume":"188","author":"AM Thornton","year":"1998","unstructured":"Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287\u2013296","journal-title":"J Exp Med"},{"key":"851_CR12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20062129","volume":"204","author":"T Bopp","year":"2007","unstructured":"Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E (2007) Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204:1303\u20131310","journal-title":"J Exp Med"},{"key":"851_CR13","doi-asserted-by":"crossref","unstructured":"Ring S, Karakhanova S, Johnson T, Enk AH, Mahnke K (2010) Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8(+) T cells. J Allergy Clin Immunol 125:237\u2013246, e231\u2013e237","DOI":"10.1016\/j.jaci.2009.10.025"},{"key":"851_CR14","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.4049\/jimmunol.0902041","volume":"183","author":"N Jain","year":"2009","unstructured":"Jain N, Nguyen H, Friedline RH, Malhotra N, Brehm M, Koyanagi M, Bix M, Cooper JA, Chambers CA, Kang J (2009) Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function. J Immunol 183:4192\u20134196","journal-title":"J Immunol"},{"key":"851_CR15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/embor.2008.224","volume":"10","author":"B Huang","year":"2009","unstructured":"Huang B, Zhao J, Lei Z, Shen S, Li D, Shen GX, Zhang GM, Feng ZH (2009) miR-142\u20133p restricts cAMP production in CD4+CD25\u2212 T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 10:180\u2013185","journal-title":"EMBO Rep"},{"key":"851_CR16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.bi.37.070168.001053","volume":"37","author":"GA Robison","year":"1968","unstructured":"Robison GA, Butcher RW, Sutherland EW (1968) Cyclic AMP. Annu Rev Biochem 37:149\u2013174","journal-title":"Annu Rev Biochem"},{"key":"851_CR17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0167-5699(88)91220-0","volume":"9","author":"GM Kammer","year":"1988","unstructured":"Kammer GM (1988) The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 9:222\u2013229","journal-title":"Immunol Today"},{"key":"851_CR18","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/eji.200636510","volume":"37","author":"J Bodor","year":"2007","unstructured":"Bodor J, Fehervari Z, Diamond B, Sakaguchi S (2007) ICER\/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells. Eur J Immunol 37:884\u2013895","journal-title":"Eur J Immunol"},{"key":"851_CR19","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1074\/jbc.273.16.9544","volume":"273","author":"J Bodor","year":"1998","unstructured":"Bodor J, Habener JF (1998) Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes. J Biol Chem 273:9544\u20139551","journal-title":"J Biol Chem"},{"key":"851_CR20","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1074\/jbc.M511235200","volume":"281","author":"P Bedner","year":"2006","unstructured":"Bedner P, Niessen H, Odermatt B, Kretz M, Willecke K, Harz H (2006) Selective permeability of different connexin channels to the second messenger cyclic AMP. J Biol Chem 281:6673\u20136681","journal-title":"J Biol Chem"},{"key":"851_CR21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1042\/bst0290606","volume":"29","author":"WH Evans","year":"2001","unstructured":"Evans WH, Boitano S (2001) Connexin mimetic peptides: specific inhibitors of gap-junctional intercellular communication. Biochem Soc Trans 29:606\u2013612","journal-title":"Biochem Soc Trans"},{"key":"851_CR22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204:1257\u20131265","journal-title":"J Exp Med"},{"key":"851_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2008.12.002","volume":"30","author":"MV Sitkovsky","year":"2009","unstructured":"Sitkovsky MV (2009) T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol 30:102\u2013108","journal-title":"Trends Immunol"},{"key":"851_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ni1289","volume":"7","author":"Q Tang","year":"2006","unstructured":"Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, Santamaria P, Locksley RM, Krummel MF, Bluestone JA (2006) Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7:83\u201392","journal-title":"Nat Immunol"},{"key":"851_CR25","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.20050783","volume":"203","author":"CE Tadokoro","year":"2006","unstructured":"Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC, Maraver A, Lafaille JJ, Dustin ML (2006) Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 203:505\u2013511","journal-title":"J Exp Med"},{"key":"851_CR26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2567.2004.01768.x","volume":"111","author":"P Ozegbe","year":"2004","unstructured":"Ozegbe P, Foey AD, Ahmed S, Williams RO (2004) Impact of cAMP on the T-cell response to type II collagen. Immunology 111:35\u201340","journal-title":"Immunology"},{"key":"851_CR27","doi-asserted-by":"crossref","first-page":"32507","DOI":"10.1074\/jbc.M403355200","volume":"279","author":"M Galgani","year":"2004","unstructured":"Galgani M, De Rosa V, De Simone S, Leonardi A, D\u2019Oro U, Napolitani G, Masci AM, Zappacosta S, Racioppi L (2004) Cyclic AMP modulates the functional plasticity of immature dendritic cells by inhibiting Src-like kinases through protein kinase A-mediated signaling. J Biol Chem 279:32507\u201332514","journal-title":"J Biol Chem"},{"key":"851_CR28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1189\/jlb.70.6.903","volume":"70","author":"T Kambayashi","year":"2001","unstructured":"Kambayashi T, Wallin RP, Ljunggren HG (2001) cAMP-elevating agents suppress dendritic cell function. J Leukoc Biol 70:903\u2013910","journal-title":"J Leukoc Biol"},{"key":"851_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jlb.63.1.101","volume":"63","author":"A Eigler","year":"1998","unstructured":"Eigler A, Siegmund B, Emmerich U, Baumann KH, Hartmann G, Endres S (1998) Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol 63:101\u2013107","journal-title":"J Leukoc Biol"},{"key":"851_CR30","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1182\/blood-2005-10-4190","volume":"107","author":"S Fujita","year":"2006","unstructured":"Fujita S, Seino K, Sato K, Sato Y, Eizumi K, Yamashita N, Taniguchi M (2006) Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107:3656\u20133664","journal-title":"Blood"},{"key":"851_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.20061196","volume":"204","author":"H Hammad","year":"2007","unstructured":"Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, Hoogsteden HC, Lambrecht BN (2007) Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204:357\u2013367","journal-title":"J Exp Med"},{"key":"851_CR32","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.4049\/jimmunol.0803310","volume":"182","author":"T Bopp","year":"2009","unstructured":"Bopp T, Dehzad N, Reuter S, Klein M, Ullrich N, Stassen M, Schild H, Buhl R, Schmitt E, Taube C (2009) Inhibition of cAMP degradation improves regulatory T cell-mediated suppression. J Immunol 182:4017\u20134024","journal-title":"J Immunol"},{"key":"851_CR33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187152807780077318","volume":"6","author":"W Baumer","year":"2007","unstructured":"Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M (2007) Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. Inflamm Allergy Drug Targets 6:17\u201326","journal-title":"Inflamm Allergy Drug Targets"},{"key":"851_CR34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","volume":"7","author":"M Delgado","year":"2001","unstructured":"Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP (2001) Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7:563\u2013568","journal-title":"Nat Med"},{"key":"851_CR35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1096\/fj.05-4909fje","volume":"20","author":"R Aricha","year":"2006","unstructured":"Aricha R, Feferman T, Souroujon MC, Fuchs S (2006) Overexpression of phosphodiesterases in experimental autoimmune myasthenia gravis: suppression of disease by a phosphodiesterase inhibitor. FASEB J 20:374\u2013376","journal-title":"FASEB J"},{"key":"851_CR36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","volume":"9","author":"M Edinger","year":"2003","unstructured":"Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9:1144\u20131150","journal-title":"Nat Med"},{"key":"851_CR37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbmt.2007.01.071","volume":"13","author":"MJ O\u2019Shaughnessy","year":"2007","unstructured":"O\u2019Shaughnessy MJ, Chen ZM, Gramaglia I, Taylor PA, Panoskaltsis-Mortari A, Vogtenhuber C, Palmer E, Grader-Beck T, Boussiotis VA, Blazar BR (2007) Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo. Biol Blood Marrow Transpl 13:530\u2013542","journal-title":"Biol Blood Marrow Transpl"},{"key":"851_CR38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00262-007-0417-x","volume":"57","author":"S Yaqub","year":"2008","unstructured":"Yaqub S, Henjum K, Mahic M, Jahnsen FL, Aandahl EM, Bjornbeth BA, Tasken K (2008) Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Cancer Immunol Immunother 57:813\u2013821","journal-title":"Cancer Immunol Immunother"},{"key":"851_CR39","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1523\/JNEUROSCI.0600-04.2004","volume":"24","author":"J Kipnis","year":"2004","unstructured":"Kipnis J, Cardon M, Avidan H, Lewitus GM, Mordechay S, Rolls A, Shani Y, Schwartz M (2004) Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity: implications for neurodegeneration. J Neurosci 24:6133\u20136143","journal-title":"J Neurosci"},{"key":"851_CR40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1081\/RRS-200029981","volume":"24","author":"KA Neve","year":"2004","unstructured":"Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165\u2013205","journal-title":"J Recept Signal Transduct Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0851-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-010-0851-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0851-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T17:53:05Z","timestamp":1685555585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-010-0851-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,2]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["851"],"URL":"https:\/\/doi.org\/10.1007\/s00262-010-0851-z","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,2]]}}}